Viking Therapeutics
VKTX
#3604
Rank
โ‚ฌ2.45 B
Marketcap
21,84ย โ‚ฌ
Share price
-3.31%
Change (1 day)
-64.09%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -โ‚ฌ0.11 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ75.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ96.79 Million28.02%
2023 -โ‚ฌ75.61 Million24.73%
2022 -โ‚ฌ60.62 Million25.24%
2021 -โ‚ฌ48.41 Million39.23%
2020 -โ‚ฌ34.77 Million53.21%
2019 -โ‚ฌ22.7 Million16.84%
2018 -โ‚ฌ19.42 Million7.22%
2017 -โ‚ฌ18.12 Million39.68%
2016 -โ‚ฌ12.97 Million-37.05%
2015 -โ‚ฌ20.61 Million6.94%
2014 -โ‚ฌ19.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.45 Billion 358.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.31 M-103.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ5.55 Million-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA